Celldex Therapeutics, Inc. (CLDX)
28.25
-1.68
(-5.61%)
USD |
NASDAQ |
Nov 05, 16:00
27.87
-0.38
(-1.35%)
After-Hours: 20:00
Celldex Therapeutics Price : 28.25 for Nov. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2026 | 30.53 | 30.92 | 28.78 | 29.93 | 911485.0 |
| Nov 03, 2026 | 29.36 | 29.96 | 28.67 | 29.71 | 872045.0 |
| Nov 02, 2026 | 30.10 | 30.17 | 28.61 | 29.04 | 956133.0 |
| Oct 30, 2026 | 29.70 | 30.27 | 29.20 | 30.10 | 870776.0 |
| Oct 29, 2026 | 29.79 | 30.38 | 29.46 | 29.89 | 918867.0 |
| Oct 28, 2026 | 29.63 | 30.02 | 28.92 | 29.66 | 899158.0 |
| Oct 27, 2026 | 29.50 | 30.40 | 29.33 | 30.15 | 746583.0 |
| Oct 26, 2026 | 29.37 | 29.90 | 28.98 | 29.50 | 593368.0 |
| Oct 23, 2026 | 28.95 | 29.38 | 28.20 | 29.25 | 879734.0 |
| Oct 22, 2026 | 29.08 | 29.72 | 28.49 | 28.97 | 877932.0 |
| Oct 21, 2026 | 30.29 | 30.72 | 29.31 | 29.37 | 1.118M |
| Oct 20, 2026 | 29.99 | 30.82 | 29.60 | 30.29 | 1.100M |
| Oct 19, 2026 | 27.73 | 29.84 | 27.50 | 29.67 | 1.719M |
| Oct 16, 2026 | 28.89 | 28.89 | 27.46 | 27.53 | 997972.0 |
| Oct 15, 2026 | 28.05 | 28.95 | 27.65 | 28.93 | 1.182M |
| Oct 14, 2026 | 28.49 | 28.73 | 27.68 | 27.84 | 1.044M |
| Oct 13, 2026 | 29.28 | 29.28 | 27.92 | 28.25 | 1.898M |
| Oct 12, 2026 | 29.61 | 30.02 | 28.99 | 29.43 | 596417.0 |
| Oct 09, 2026 | 29.04 | 30.26 | 28.88 | 29.89 | 992779.0 |
| Oct 08, 2026 | 30.07 | 30.10 | 28.63 | 29.30 | 3.950M |
| Oct 07, 2026 | 30.62 | 31.35 | 30.10 | 30.43 | 1.747M |
| Oct 06, 2026 | 32.68 | 32.68 | 30.85 | 31.00 | 1.768M |
| Oct 05, 2026 | 31.83 | 32.88 | 31.50 | 32.59 | 1.258M |
| Oct 02, 2026 | 32.26 | 32.54 | 30.98 | 31.65 | 2.406M |
| Oct 01, 2026 | 32.26 | 32.55 | 31.70 | 32.18 | 1.443M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 21.22 |
| Alnylam Pharmaceuticals, Inc. | 156.47 |
| Anika Therapeutics, Inc. | 19.30 |
| Savara, Inc. | 4.38 |
| Vericel Corp. | 51.64 |
Price Related Metrics
| PS Ratio | 12395.80 |
| PEG Ratio | -0.1443 |
| Price to Book Value | 3.103 |
| Earnings Yield | -15.43% |
| Market Cap | 2.218B |
| PEGY Ratio | -0.1443 |